A 28-year-old primigravida presents at 8 weeks of gestation with hyperemesis gravidarum causing significant weight loss and electrolyte imbalance despite conservative management. Which is the drug of choice for pharmacological management of her nausea and vomiting?

Explanation

## Drug of Choice for Hyperemesis Gravidarum **Key Point:** Doxylamine succinate combined with pyridoxine (vitamin B6) is the first-line pharmacological agent for hyperemesis gravidarum, particularly in the first trimester, and is FDA Category A. ### Rationale for Doxylamine + Pyridoxine **High-Yield:** This combination is: - Extensively studied with an excellent safety profile in pregnancy - FDA Category A (safest category in pregnancy) - Effective for nausea and vomiting when conservative measures fail - Available as a fixed-dose combination (Diclegis®) in many countries - Supported by ACOG and RCOG guidelines as first-line pharmacotherapy ### Comparative Drug Profile | Drug | Category | Use in HEG | Mechanism | Safety | |------|----------|-----------|-----------|--------| | Doxylamine + Pyridoxine | A | First-line | Antihistamine + B6 | Excellent | | Metoclopramide | B | Second-line | D2 antagonist | Safe but not first-line | | Ondansetron | B | Reserved | 5-HT3 antagonist | Limited data; expensive | | Domperidone | C | Avoid | D2 antagonist | Peripheral action only | **Clinical Pearl:** Pyridoxine (vitamin B6) alone at 25–50 mg three times daily is often tried first before adding doxylamine, as it is safe and effective for mild-to-moderate nausea. ### Management Algorithm ```mermaid flowchart TD A[Hyperemesis Gravidarum diagnosed]:::outcome --> B[Conservative measures: small frequent meals, ginger, vitamin B6]:::action B --> C{Symptoms controlled?}:::decision C -->|Yes| D[Continue conservative management]:::action C -->|No| E[Add pharmacotherapy]:::action E --> F[Doxylamine + Pyridoxine]:::action F --> G{Response adequate?}:::decision G -->|Yes| H[Continue; reassess at 12-14 weeks]:::action G -->|No| I[Add metoclopramide or admit for IV hydration]:::action ``` **Warning:** Ondansetron, while effective, is reserved for refractory cases because of limited pregnancy safety data and cost; metoclopramide is a reasonable second-line agent but not preferred as first-line due to theoretical risk of tardive dyskinesia with prolonged use. [cite:ACOG Practice Bulletin 189]